Literature DB >> 12610097

Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction.

P A J Krijnen1, C Meischl, C E Hack, C J L M Meijer, C A Visser, D Roos, H W M Niessen.   

Abstract

BACKGROUND/AIMS: Recent studies indicate the presence of reactive oxygen species (ROS) producing homologues of the enzymatic subunit (Nox2) of phagocytic NADPH oxidase in non-phagocytic cells. Interestingly, in these cells, ROS produced by the Nox2 homologue(s) was shown to play a role in various regulatory processes, including cell death, proliferation, and aging. The purpose of this study was to investigate whether human cardiomyocytes express Nox2.
METHODS: The expression of Nox2 was studied in human cardiomyocytes using western blot and immunohistochemical analysis. To analyse the putative expression of Nox2 in human heart disease, cardiac samples from patients who had died subsequent to acute myocardial infarction (AMI) were studied.
RESULTS: Both in western blot and immunohistochemical studies, Nox2 expression was found in normal human cardiomyocytes. In patients with AMI, a significant increase in Nox2 expression was found both in viable and in jeopardised cardiomyocytes in the infarcted area. In addition, in the "remote from infarction" area, Nox2 expression was present in cardiomyocytes, but was not increased.
CONCLUSIONS: Nox2 or its homologue(s) is expressed in normal and jeopardised human cardiomyocytes. This expression is increased in patients with AMI, suggesting a role for this ROS producing Nox2 homologue(s) in the human heart after AMI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610097      PMCID: PMC1769897          DOI: 10.1136/jcp.56.3.194

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  25 in total

1.  Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

Authors:  Jennifer K Bendall; Alison C Cave; Christophe Heymes; Nicholas Gall; Ajay M Shah
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

Review 2.  Superoxide anion and endothelial regulation of arterial tone.

Authors:  Z S Katusic
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

3.  Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils.

Authors:  A J Verhoeven; B G Bolscher; L J Meerhof; R van Zwieten; J Keijer; R S Weening; D Roos
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

4.  Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis.

Authors:  R von Harsdorf; P F Li; R Dietz
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

5.  Cell transformation by the superoxide-generating oxidase Mox1.

Authors:  Y A Suh; R S Arnold; B Lassegue; J Shi; X Xu; D Sorescu; A B Chung; K K Griendling; J D Lambeth
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

6.  Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.

Authors:  B Lassègue; D Sorescu; K Szöcs; Q Yin; M Akers; Y Zhang; S L Grant; J D Lambeth; K K Griendling
Journal:  Circ Res       Date:  2001-05-11       Impact factor: 17.367

7.  Release of azurophilic granule contents in fMLP-stimulated neutrophils requires two activation signals, one of which is a rise in cytosolic free Ca2+.

Authors:  H W Niessen; T W Kuijpers; D Roos; A J Verhoeven
Journal:  Cell Signal       Date:  1991       Impact factor: 4.315

8.  Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression.

Authors:  G N Rao; B C Berk
Journal:  Circ Res       Date:  1992-03       Impact factor: 17.367

9.  Role of NADH/NADPH oxidase-derived H2O2 in angiotensin II-induced vascular hypertrophy.

Authors:  A M Zafari; M Ushio-Fukai; M Akers; Q Yin; A Shah; D G Harrison; W R Taylor; K K Griendling
Journal:  Hypertension       Date:  1998-09       Impact factor: 10.190

10.  Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis.

Authors:  C D Porter; F Kuribayashi; M H Parkar; D Roos; C Kinnon
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

View more
  60 in total

1.  Differential regulation of EHD3 in human and mammalian heart failure.

Authors:  Hjalti Gudmundsson; Jerry Curran; Farshid Kashef; Jedidiah S Snyder; Sakima A Smith; Pedro Vargas-Pinto; Ingrid M Bonilla; Robert M Weiss; Mark E Anderson; Philip Binkley; Robert B Felder; Cynthia A Carnes; Hamid Band; Thomas J Hund; Peter J Mohler
Journal:  J Mol Cell Cardiol       Date:  2012-03-03       Impact factor: 5.000

Review 2.  NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology.

Authors:  Alison Cave; David Grieve; Sofian Johar; Min Zhang; Ajay M Shah
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 3.  Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.

Authors:  Sergey I Dikalov; Rafal R Nazarewicz
Journal:  Antioxid Redox Signal       Date:  2012-05-21       Impact factor: 8.401

4.  Homocysteine-induced cardiomyocyte apoptosis and plasma membrane flip-flop are independent of S-adenosylhomocysteine: a crucial role for nuclear p47(phox).

Authors:  Jessica A Sipkens; Paul A J Krijnen; Nynke E Hahn; Melissa Wassink; Christof Meischl; Desirée E C Smith; René J P Musters; Coen D A Stehouwer; Jan A Rauwerda; Victor W M van Hinsbergh; Hans W M Niessen
Journal:  Mol Cell Biochem       Date:  2011-07-08       Impact factor: 3.396

5.  Early NADPH oxidase-2 activation is crucial in phenylephrine-induced hypertrophy of H9c2 cells.

Authors:  Nynke E Hahn; René J P Musters; Jan M Fritz; Patrick J Pagano; Alexander B A Vonk; Walter J Paulus; Albert C van Rossum; Christof Meischl; Hans W M Niessen; Paul A J Krijnen
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

6.  Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction.

Authors:  Yu-Yu Yao; Hang Yin; Bo Shen; Lee Chao; Julie Chao
Journal:  Regul Pept       Date:  2006-12-28

Review 7.  The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox.

Authors:  Demetrios Moris; Michael Spartalis; Eleftherios Spartalis; Georgia-Sofia Karachaliou; Georgios I Karaolanis; Gerasimos Tsourouflis; Diamantis I Tsilimigras; Eleni Tzatzaki; Stamatios Theocharis
Journal:  Ann Transl Med       Date:  2017-08

8.  Targeted antioxidant treatment decreases cardiac alternans associated with chronic myocardial infarction.

Authors:  Bradley N Plummer; Haiyan Liu; Xiaoping Wan; Isabelle Deschênes; Kenneth R Laurita
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-09

9.  Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation.

Authors:  Lei-Lei Chen; Tie Bin Zhu; Hang Yin; Jun Huang; Lian Sheng Wang; Ke Jiang Cao; Zhi Jian Yang
Journal:  Mol Biol Rep       Date:  2009-11-12       Impact factor: 2.316

10.  AAV-based RNAi silencing of NADPH oxidase gp91(phox) attenuates cold-induced cardiovascular dysfunction.

Authors:  Xiuqing Wang; Lucille Skelley; Bo Wang; Ayesha Mejia; Val Sapozhnikov; Zhongjie Sun
Journal:  Hum Gene Ther       Date:  2012-08-13       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.